Zimmer Biomet Holdings Total Assets 2006-2019 | ZBH

Zimmer Biomet Holdings total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Zimmer Biomet Holdings total assets for the quarter ending June 30, 2019 were $24.206B, a 5.04% decline year-over-year.
  • Zimmer Biomet Holdings total assets for 2018 were $24.127B, a 7.25% decline from 2017.
  • Zimmer Biomet Holdings total assets for 2017 were $26.014B, a 2.51% decline from 2016.
  • Zimmer Biomet Holdings total assets for 2016 were $26.684B, a 1.75% decline from 2015.
Zimmer Biomet Holdings Annual Total Assets
(Millions of US $)
2018 $24,127
2017 $26,014
2016 $26,684
2015 $27,161
2014 $9,658
2013 $9,581
2012 $9,012
2011 $8,515
2010 $8,000
2009 $7,786
2008 $7,239
2007 $6,634
2006 $5,974
2005 $5,722
Zimmer Biomet Holdings Quarterly Total Assets
(Millions of US $)
Q2 2019 $24,206
Q1 2019 $24,289
Q4 2018 $24,127
Q3 2018 $25,382
Q2 2018 $25,491
Q1 2018 $27,181
Q4 2017 $26,014
Q3 2017 $26,418
Q2 2017 $26,459
Q1 2017 $26,988
Q4 2016 $26,684
Q3 2016 $27,037
Q2 2016 $25,971
Q1 2016 $26,297
Q4 2015 $27,161
Q3 2015 $26,689
Q2 2015 $27,204
Q1 2015 $17,190
Q4 2014 $9,658
Q3 2014 $9,671
Q2 2014 $9,638
Q1 2014 $9,380
Q4 2013 $9,581
Q3 2013 $9,357
Q2 2013 $9,097
Q1 2013 $8,745
Q4 2012 $9,012
Q3 2012 $8,784
Q2 2012 $8,617
Q1 2012 $8,604
Q4 2011 $8,515
Q3 2011 $8,199
Q2 2011 $8,249
Q1 2011 $8,118
Q4 2010 $8,000
Q3 2010 $8,004
Q2 2010 $7,827
Q1 2010 $7,822
Q4 2009 $7,786
Q3 2009 $7,648
Q2 2009 $7,462
Q1 2009 $7,232
Q4 2008 $7,239
Q3 2008 $7,079
Q2 2008 $6,942
Q1 2008 $6,919
Q4 2007 $6,634
Q3 2007 $6,367
Q2 2007 $6,321
Q1 2007 $6,098
Q4 2006 $5,974
Q3 2006 $5,909
Q2 2006 $5,964
Q1 2006 $5,917
Q4 2005 $5,722
Q3 2005 $5,622
Q2 2005 $5,552
Q1 2005 $5,591
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $28.438B $7.933B
Zimmer Biomet Holdings, Inc. is a musculoskeletal healthcare company. The company design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Zimmer Biomet Holdings, Inc., formerly known as Zimmer Holdings, Inc., is based in Warsaw, United States.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $145.598B 26.57
Medtronic (MDT) Ireland $145.585B 20.43
Stryker (SYK) United States $80.642B 27.89
Boston Scientific (BSX) United States $53.170B 25.79
Baxter (BAX) United States $44.852B 27.20
EssilorLuxottica Societe Anonyme (ESLOY) France $32.725B 0.00
Coloplast (CLPBY) Denmark $25.747B 41.10
Lonza Group Ag (LZAGY) Switzerland $25.481B 0.00
Terumo (TRUMY) Japan $24.495B 30.57
Smith & Nephew SNATS (SNN) United Kingdom $20.928B 0.00
ResMed (RMD) United States $18.924B 36.06
Sunny Optical Technology (SNPTF) China $16.014B 0.00
Bio-Rad Laboratories (BIO) United States $10.234B 54.86
Insulet (PODD) United States $9.431B 558.86
Perrigo (PRGO) Ireland $7.400B 13.63
Canopy Growth (CGC) Canada $7.222B 0.00
Hill-Rom Holdings (HRC) United States $6.830B 20.36
Haemonetics (HAE) United States $6.455B 48.71
William Demant Holdings (WILYY) Denmark $5.988B 0.00
GN STORE NORD (GNNDY) Denmark $5.344B 27.61
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Aurora Cannabis (ACB) Canada $4.002B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.680B 0.00
Neogen (NEOG) United States $3.490B 58.40
NuVasive (NUVA) United States $3.398B 27.09
ICU Medical (ICUI) United States $3.237B 21.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.634B 0.00
Quidel (QDEL) United States $2.510B 24.93
Agios Pharmaceuticals (AGIO) United States $1.982B 0.00
National Vision Holdings (EYE) United States $1.877B 40.51
Cardiovascular Systems (CSII) United States $1.670B 0.00
Aphria (APHA) $1.242B 0.00
VAREX IMAGING (VREX) United States $1.124B 25.90
AtriCure (ATRC) United States $1.059B 0.00
Phibro Animal Health (PAHC) United States $0.867B 14.10
Eagle Pharmaceuticals (EGRX) United States $0.854B 21.78
NanoString Technologies (NSTG) United States $0.787B 0.00
Omeros (OMER) United States $0.759B 0.00
Lantheus Holdings (LNTH) United States $0.734B 19.29
PetIQ (PETQ) United States $0.725B 17.13
LeMaitre Vascular (LMAT) United States $0.689B 40.82
Cerus (CERS) United States $0.624B 0.00
Surmodics (SRDX) United States $0.621B 118.00
MacroGenics (MGNX) United States $0.560B 0.00
Quanterix (QTRX) United States $0.548B 0.00
TG Therapeutics (TGTX) United States $0.530B 0.00
OraSure Technologies (OSUR) United States $0.523B 24.23
Owens & Minor (OMI) United States $0.459B 13.76
Meridian Bioscience (VIVO) United States $0.427B 13.32
Utah Medical Products (UTMD) United States $0.354B 25.91
Zynex (ZYXI) United States $0.346B 36.76
BioLife Solutions (BLFS) United States $0.339B 104.19
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.327B 0.00
Bovie Medical (APYX) United States $0.234B 0.00
United Health Products (UEEC) United States $0.208B 0.00
Vapotherm (VAPO) United States $0.177B 0.00
Rockwell Medical (RMTI) United States $0.153B 0.00
Cytosorbents (CTSO) United States $0.147B 0.00
Female Health (VERU) United States $0.138B 0.00
Fonar (FONR) United States $0.133B 9.32
InfuSystems Holdings (INFU) United States $0.127B 0.00
Liberty Health Sciences (LHSIF) Canada $0.104B 0.00
Chembio Diagnostics (CEMI) United States $0.097B 0.00
Chimerix (CMRX) United States $0.088B 0.00
Nephros (NEPH) United States $0.087B 0.00
United-Guardian (UG) United States $0.084B 19.82
MTech Acquisition (KERN) United States $0.063B 0.00
MRI Interventions (MRIC) United States $0.058B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.053B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
Surface Oncology (SURF) United States $0.039B 0.00
Senestech (SNES) United States $0.023B 0.00
Trinity Biotech (TRIB) Ireland $0.020B 0.00
GUARDION HEALTH (GHSI) United States $0.018B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.013B 0.00
Myomo (MYO) United States $0.010B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00